Voluntary Announcement – New Drug Application of Socazolimab for Treatment of Recurrent or Metastatic Cervical Cancer Submitted and Accepted by NMPA | Lee's Pharmaceutical
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
